Medicines co /de (MDCO)
Income statement / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
Net revenues

0

-3,300

-1,633

6,138

14,733

25,901

35,095

44,789

36,719

66,450

110,320

143,161

195,343

214,950

234,738

294,547

368,120

483,315

592,570

659,690

655,157

657,038

646,090

624,608

662,351

624,855

587,731

558,588

531,329

515,316

499,205

484,732

472,180

457,150

447,694

437,645

416,755

415,187

0

0

0

Net product revenues

-

-

-

-

-

-

-

-

-

-

-

-

103,893

117,753

161,948

240,688

389,738

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty revenues

-

-

-

-

-

-

-

-

-

-

-

-

91,450

97,197

72,790

53,859

24,503

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Cost of revenues

697

1,587

4,518

7,255

26,996

30,393

39,952

47,193

32,604

49,094

51,834

60,653

64,308

92,719

102,245

103,986

106,182

126,070

187,001

233,330

251,820

248,538

226,789

216,636

238,674

216,647

195,390

177,339

169,118

164,810

159,959

156,866

148,253

140,362

136,100

129,299

122,213

120,998

0

0

0

Asset impairment charges

0

-

-

-

0

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

127,504

117,470

119,652

133,007

158,996

159,337

152,292

138,370

80,282

70,742

85,060

92,107

101,563

105,128

100,596

90,388

117,294

123,506

131,699

139,512

135,490

125,363

111,160

138,260

134,555

145,904

151,841

126,423

133,578

125,592

119,166

110,180

107,991

98,117

92,156

85,241

76,592

81,700

0

0

0

Selling, general and administrative

50,894

39,121

40,245

52,214

86,434

113,373

120,719

132,225

72,585

107,842

173,641

212,482

266,792

284,662

283,813

285,300

340,012

335,782

331,218

314,954

304,797

284,663

248,862

247,823

223,658

204,526

192,049

171,753

161,965

163,922

164,875

159,617

162,073

152,508

150,497

158,690

168,676

178,798

0

0

0

Total operating expenses

179,095

163,251

169,488

197,549

340,499

366,103

705,060

709,885

514,568

556,775

310,535

365,242

432,663

482,509

486,654

479,674

563,488

585,358

649,918

687,796

692,107

658,564

586,811

602,719

596,887

567,077

539,280

475,515

464,661

454,324

444,000

426,663

418,317

390,987

378,753

373,230

367,481

381,496

0

0

0

Loss from operations

-179,095

-166,551

-171,121

-191,411

-325,766

-340,202

-669,965

-665,096

-477,849

-490,325

-200,215

-222,081

-237,320

-267,559

-251,916

-185,127

-195,368

-102,043

-57,348

-28,106

-36,950

-1,526

59,279

21,889

65,464

57,778

48,451

83,073

66,668

60,992

55,205

58,069

53,863

66,163

68,941

64,415

49,274

33,691

0

0

0

Legal settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

17,984

17,984

17,984

17,984

0

0

0

0

-

-

Co-promotion and license income

4,668

537

791

1,019

6,019

6,517

7,020

7,549

3,064

3,052

3,636

3,854

3,194

3,422

2,719

10,132

18,037

19,916

26,604

24,236

21,352

22,911

19,653

17,383

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on short-term investment

-10,481

-16,581

-22,181

-51,881

-41,500

-33,500

-30,000

0

0

0

0

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on remeasurement of equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22,597

22,741

22,741

22,741

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of business

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Co-promotion and profit share income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,000

6,250

2,500

0

-

0

0

-

-

-

-

-

-

-

Loss in equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,855

-1,711

-1,184

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

60,940

57,041

53,358

49,411

48,309

47,806

48,219

48,564

49,018

49,297

47,139

44,463

41,780

39,238

38,223

37,092

31,501

25,912

20,456

15,701

16,098

15,905

15,717

15,531

14,759

14,599

11,679

8,005

4,389

784

0

-

0

0

-

-

-

-

-

-

-

Investment impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

4,235

4,266

3,632

5,580

4,789

4,118

4,098

1,840

1,197

1,614

719

346

320

-634

-541

188

1,551

1,587

1,206

918

210

646

1,401

1,420

1,363

1,184

1,276

1,140

1,303

1,677

1,041

1,790

1,128

1,033

855

-267

206

457

0

0

0

Loss from continuing operations before income taxes

-241,699

-235,416

-242,214

-286,104

-404,683

-410,836

-737,055

-704,271

-522,606

-534,956

39,922

20,577

7,335

-16,088

-263,188

-164,529

-134,702

-47,557

-10,872

-2,128

-40,170

6,126

64,616

25,161

68,059

59,681

51,798

86,208

69,832

64,385

56,246

77,843

72,975

85,180

87,780

64,148

49,480

34,148

0

0

0

(Provision for) benefit from income taxes

-3,465

-19,575

-31,985

-50,888

-54,368

-104,904

-115,504

-96,576

-89,761

-22,962

49

67

-16,618

-35,782

-33,688

-29,733

-8,178

5,130

-20,403

-2,309

-21,916

-155

35,127

2,273

33,304

23,408

19,805

35,038

19,661

-49,136

-54,961

-50,034

-93,892

-30,278

-31,664

-40,487

6,614

8,676

0

0

0

Loss from continuing operations

-238,206

-215,847

-210,245

-235,216

-350,340

-305,923

-621,535

-607,695

-432,841

-511,977

39,911

20,564

24,009

19,746

-229,522

-134,806

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) income from discontinued operations, net of tax

1,818

-2,181

-1,925

112,060

91,398

72,440

44,981

-100,678

-220,126

-197,073

-169,251

-139,682

-226,339

-240,950

-220,716

-217,950

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-54

-56

-52

22

10

-43

-87

-157

-138

-191

-185

-228

-252

-222

-176

-117

-84

-2

-1

0

-

0

0

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

0

0

-

-

0

0

-

-708,373

-652,967

-709,050

-129,340

-119,118

-202,330

-221,204

-450,238

-352,756

-152,011

-63,615

-22,180

-32,210

-25,691

-1,162

22,089

15,512

34,893

36,365

32,026

51,170

50,173

113,522

111,207

127,877

166,867

115,458

119,444

104,635

42,866

25,472

0

0

0

(Loss) income from continuing operations

-

-

-

-

-

-

-

-

-

-

-

20,510

23,953

19,694

-229,500

-134,796

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations, net of tax

-

-

-

-

-

-

-

-

-

-

-

-

-226,339

-240,950

-220,716

-217,950

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-

-

0

-

-

-

0

-

-

-

-

-119,172

-202,386

-221,256

-450,216

-352,746

-152,054

-63,702

-22,337

-32,348

-25,882

-1,347

21,861

15,260

34,839

36,357

32,077

51,254

103,203

105,379

0

-

0

0

-

-

-

-

-

-

-

Net loss attributable to The Medicines Company

0

0

-

-

0

0

-

-708,373

-652,967

-709,050

-129,340

-119,118

-202,330

-221,204

-450,238

-352,756

-152,011

-63,615

-22,180

-32,210

-25,691

-1,162

22,089

15,512

34,893

36,365

32,026

51,170

50,173

113,522

111,207

127,877

166,867

115,458

119,444

104,635

42,866

25,472

0

0

0

Basic loss per common share:
Loss from continuing operations (USD per share)

-0.92

-0.80

-0.80

-0.61

-0.70

-0.74

-1.15

-2.15

-0.10

-5.15

-1.00

0.22

-1.23

2.61

-1.31

0.28

-1.35

-1.02

0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) earnings from discontinued operations (USD per share)

0.00

0.00

0.00

0.03

-0.05

0.00

1.54

-0.25

-0.32

-0.38

-0.44

-1.98

0.00

0.01

-0.03

-3.36

-0.22

0.31

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic loss per share (USD per share)

-0.92

-0.80

-0.80

-0.58

-0.75

-0.74

0.39

-2.40

-0.42

-5.53

-1.44

-1.76

-1.23

2.62

-1.34

-3.08

-1.57

-0.71

0.08

-0.08

-0.26

-0.08

-0.08

0.02

0.13

0.33

-0.21

0.39

0.18

0.25

0.14

0.36

1.36

0.21

0.46

1.11

0.40

0.29

0.18

-0.06

0.07

Diluted loss per common share:
Loss from continuing operations (USD per share)

-0.92

-0.80

-0.80

-0.61

-0.70

-0.74

-1.15

-2.15

-0.10

-5.15

-1.00

0.31

-1.23

2.51

-1.31

0.28

-1.35

-1.02

0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) earnings from discontinued operations (USD per share)

0.00

0.00

0.00

0.03

-0.05

0.00

1.54

-0.25

-0.32

-0.38

-0.44

-1.89

0.00

0.01

-0.03

-3.36

-0.22

0.31

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted loss per share (USD per share)

-0.92

-0.80

-0.80

-0.58

-0.75

-0.74

0.39

-2.40

-0.42

-5.53

-1.44

-1.58

-1.23

2.52

-1.34

-3.08

-1.57

-0.71

0.08

-0.07

-0.26

-0.08

-0.08

0.04

0.12

0.30

-0.21

0.37

0.17

0.25

0.14

0.35

1.34

0.21

0.45

1.10

0.40

0.29

0.18

-0.06

0.07

Weighted average number of common shares outstanding:
Basic (shares)

80,129

74,809

74,463

73,589

73,544

73,349

73,802

74,147

72,286

71,918

71,073

70,521

70,194

69,711

69,210

69,022

67,137

65,903

65,174

64,806

64,534

64,400

64,152

63,553

59,231

55,553

54,047

53,212

52,896

54,035

54,037

53,785

53,534

53,441

53,224

105,505

52,991

52,819

52

52,298

52,232

Diluted (shares)

80,129

74,809

74,463

73,589

73,544

73,349

73,802

74,147

72,286

71,918

71,073

80,175

70,194

72,509

69,210

67,267

67,137

65,903

66,929

73,586

64,534

64,400

64,152

73,127

63,173

60,261

54,047

55,011

55,145

55,556

55,672

54,945

54,260

54,314

54,109

106,400

53,359

52,924

52

52,298

52,532